UK's NICE stamps ap­proval on Al­ny­lam, PTC rare dis­ease drugs

The UK’s Na­tion­al In­sti­tute for Health and Care Ex­cel­lence (NICE) is play­ing nice with Al­ny­lam and PTC Ther­a­peu­tics, en­dors­ing rare dis­ease treat­ments from both com­pa­nies …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER